论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
中国某大学医院 ICU 和呼吸科患者耐碳青霉烯鲍曼不动杆菌的分子流行病学及机制
Authors Liu B, Liu L
Received 29 December 2020
Accepted for publication 6 February 2021
Published 25 February 2021 Volume 2021:14 Pages 743—755
DOI https://doi.org/10.2147/IDR.S299540
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Sahil Khanna
Background: The objective of our study is to estimate the differences in molecular epidemiology and resistance mechanisms in carbapenem-resistant Acinetobacter baumannii (CRAB) isolates from the ICU and respiratory department(RD) in Fourth Affiliated Hospital of Harbin Medical University.
Methods: Carbapenemase genes associated with carbapenem resistance were studied by polymerase chain reaction(PCR). Genotyping was analyzed using multi-locus sequence typing (MLST) and pulsed field gel electrophoresis (PFGE).
Results: Sixty non-duplicate CRAB isolates from the ICU and RD (n=30, respectively) were collected. All of CRAB strains were not resistant to colistin (0%). The CRAB strains from the ICU were significantly more resistant to tigecycline and cefoperazone/sulbactam compared with the RD (23.3% vs 0%, P=0.03; 53.3% % vs 23.3%, P=0.01, respectively). PCR detection of genes associated with CRAB revealed that the ratio in both the ICU and the RD of bla VIM-2, bla IMP-4, bla NDM-1, bla OXA-23, ampC , and mutation of CarO were present in 23.3% vs 0% (P=0.01), 40% vs 10% (P=0.02), 20% vs 0% (P=0.02), 80% vs 56.7%, 16.7% vs 13.3% and 86.7% vs 60% (P=0.04), respectively. Seven genotypes were detected by the PFGE in the RD and the ICU, respectively. Genotype I was significantly more frequent in the ICU compared with the RD (63.3% vs 36.6%, P=0.03). MLST showed that there were 10 ST genotypes in the RD and four in the ICU, but ST92 in both groups was 33.3% vs 63.3% (P=0.03), respectively.
Conclusion: There are differences in molecular epidemiology and resistance mechanisms in the CRAB isolates between the ICU and RD.
Keywords: Acinetobacter baumannii , carbapenem resistance, molecular epidemiology, resistance mechanisms